YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Xtandi® (enzalutamide) is indicated as monotherapy for the treatment of patients with non-metastatic prostate cancer (nmCSPC) at high risk of metastasis and for the treatment of patients with metastatic prostate cancer (mCSPC) who are main…
(RTTNews) - Galmed Pharmaceuticals Ltd. (GLMD) fell more than 16% after the company announced a definitive agreement to acquire Colospan Ltd., a commercial-stage medical device company focused on colorectal surgery. Colospan's flagship pro…
Late Breaking Abstract titled "TargetingSCD1 enhances activity of standard of care regorafenib in hepatocellular carcinoma: translational rationale for a phase 1/2 study of the combination of Aramchol and regorafenib" to be presented with…
(RTTNews) - Galmed Pharmaceuticals Ltd. (GLMD), a clinical-stage biopharmaceutical company, reported a loss in the third quarter loss and also provided updates on its pipeline programs advancing treatments for chronic inflammatory and live…
DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Markets open this morning with a distinctly biotech-heavy narrative delivering milestone developments. Zymeworks and Jazz Drop Landmark Phase 3 Data: Ziihera Positioned as New HER2 Standard in Firs…
[FDA headquarters in Washington DC.] JHVEPhoto Drug developers with products targeting a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Wednesday after the U.S. FDA said it has accepted an e…
* Galmed Pharmaceuticals (NASDAQ:GLMD [https://seekingalpha.com/symbol/GLMD]) filed to sell 7.5M shares of common stock for holders. * This preliminary prospectus is not an offer to sell. * Filing [https://seekingalpha.com/filing/10318739]…
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamental…
In this piece, we will take a look at ten oversold global stocks to buy. If you want to skip our analysis of the global economic climate, then take a look at 5 Oversold Global Stocks To Buy. Like July, August is full of surprises on the da…
Endo International plc’s ENDP wholly owned subsidiary, Endo Ventures Limited, has entered into an agreement with Quoin Pharmaceuticals Inc. QNRX for the development, supply, commercialization and distribution of the latter’s pipeline candi…
Aldeyra Therapeutics, Inc. ALDX announced positive data from the vehicle-controlled crossover clinical study which evaluated its investigational product candidate, 0.25% reproxalap ophthalmic solution, for the treatment of dry eye disease.…
Evotec SE EVO announced that it has entered into a drug discovery collaboration deal with Janssen Pharmaceutical NV, a wholly owned subsidiary of Johnson & Johnson JNJ. According to the deal, Evotec’s innovative TargetAlloMod platforms wil…
In this article, we take a look at the 10 penny stocks that are trending on Reddit. If you want to skip reading about how penny stocks have exploded in the past, you can go directly to These 5 Penny Stocks are Trending on Reddit. Buy Low,…
Gainers Autolus Therapeutics plc (NASDAQ: AUTL) rose 32.6% to $7.37 in pre-market trading. Syncona said Blackstone Life Science will invest $250 million in Autolus. Mainz Biomed B.V. (NASDAQ: MYNZ) rose 28.3% to $12.82 in pre-market tradin…
Trillium Therapeutics Inc. TRIL entered into a definitive agreement with pharma giant Pfizer PFE, whereby it will be acquired by the latter. Per the terms, Pfizer will acquire all outstanding shares of Trillium for an equity value of $2.26…
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results. Earnings momentum sent shares of Bristol-Myers Squibb Company (NYS…
Galmed Pharmaceuticals (GLMD) is a clinical-stage biopharmaceutical company focused on developing Aramchol, a stearoyl-coenzyme A desaturase‑1 (SCD1) modulator that targets the liver. Aramchol is a novel oral therapy for the treatment of N…
SUZHOU, China and ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-rela…
SUZHOU, China and ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-rela…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO) Anixa Biosciences, Inc. (NASDAQ: ANIX) BioAtla, Inc. (NA…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) AngioDynamics, Inc. (NASDAQ: ANGO) Anixa Biosciences, Inc. (NASDAQ: ANIX) BioAtla, Inc. (NA…
Biotech stocks snapped back from their weekly losses and ended higher for the week ended March 12, with the broader market recovery partly aiding the reversal. Entera Bio Ltd. (NASDAQ: ENTX) was the biggest gainer of the week after it disc…
Is a pause to the stock market’s continued surge finally in the cards? The talk has turned to rising interest rates and the specter of inflation against the backdrop of growth powered by Covid fiscal stimulus. However, strategists say ther…
Is a pause to the stock market’s continued surge finally in the cards? The talk has turned to rising interest rates and the specter of inflation against the backdrop of growth powered by Covid fiscal stimulus. However, strategists say ther…
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, s…
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 817 world-class investment firms that we…
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, techn…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 11) Beam Therapeutics Inc (NASDAQ: BEAM) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN) Cel…
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 10) Amicus Therapeutics, Inc. (NASDAQ: FOLD) Celldex Therapeutics, Inc. (NASDAQ: CLDX) Denali Th…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 9) Alcon AG (NYSE: ALC) Aligos Therapeutics Inc (NASDAQ: ALGS) Aptevo Therapeutics Inc (NASDAQ:…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 9) Alcon AG (NYSE: ALC) Aligos Therapeutics Inc (NASDAQ: ALGS) Aptevo Therapeutics Inc (NASDAQ:…
SHANGHAI and TEL-AVIV, Israel, Sept. 9, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announces today that they have entered into a…
SHANGHAI and TEL-AVIV, Israel, Sept. 9, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announces today that they have entered into a…
Genfit's (NASDAQ:GNFT) loss may be a gain for other companies developing a treatment for one of the most rapidly growing health problems around the world, particularly Intercept Pharmaceuticals Inc. (NASDAQ:ICPT). Shares of Lille, France-b…
NEW YORK, April 17, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Galmed Pharmaceutica…
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of COUPA SOFTWARE (NASDA…